BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11252112)

  • 1. Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction.
    Krumholz HM; Chen YT; Wang Y; Radford MJ
    Arch Intern Med; 2001 Feb; 161(4):538-44. PubMed ID: 11252112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.
    Berger AK; Duval S; Krumholz HM
    J Am Coll Cardiol; 2003 Jul; 42(2):201-8. PubMed ID: 12875751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
    J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
    Peterson JG; Topol EJ; Sapp SK; Young JB; Lincoff AM; Lauer MS
    Am J Med; 2000 Oct; 109(5):371-7. PubMed ID: 11020393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction.
    Shlipak MG; Browner WS; Noguchi H; Massie B; Frances CD; McClellan M
    Am J Med; 2001 Apr; 110(6):425-33. PubMed ID: 11331052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function.
    Frances CD; Noguchi H; Massie BM; Browner WS; McClellan M
    Arch Intern Med; 2000 Sep; 160(17):2645-50. PubMed ID: 10999979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants.
    Michaels AD; Maynard C; Every NR; Barron HV
    Am J Cardiol; 1999 Nov; 84(10):1176-81. PubMed ID: 10569326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
    Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?
    Pilote L; Abrahamowicz M; Rodrigues E; Eisenberg MJ; Rahme E
    Ann Intern Med; 2004 Jul; 141(2):102-12. PubMed ID: 15262665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U; Jünger C; Zahn R; Bauer T; Bestehorn K; Senges J; Gitt A
    Curr Med Res Opin; 2011 Aug; 27(8):1563-70. PubMed ID: 21682553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
    Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
    Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy improves survival after acute myocardial infarction in the elderly with chronic kidney disease.
    Krause MW; Massing M; Kshirsagar A; Rosamond W; Simpson RJ
    Ren Fail; 2004 Nov; 26(6):715-25. PubMed ID: 15600265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction.
    Kvan E; Reikvam A;
    Eur J Clin Pharmacol; 2004 May; 60(3):205-10. PubMed ID: 15034703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group.
    Latini R; Tognoni G; Maggioni AP; Baigent C; Braunwald E; Chen ZM; Collins R; Flather M; Franzosi MG; Kjekshus J; Køber L; Liu LS; Peto R; Pfeffer M; Pizzetti F; Santoro E; Sleight P; Swedberg K; Tavazzi L; Wang W; Yusuf S
    J Am Coll Cardiol; 2000 Jun; 35(7):1801-7. PubMed ID: 10841227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age.
    Krumholz HM; Vaccarino V; Ellerbeck EF; Kiefe C; Hennen J; Kresowik TF; Gold JA; Jencks SF; Radford MJ
    Am J Cardiol; 1997 Mar; 79(5):581-6. PubMed ID: 9068512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is ramipril really better than other angiotensin-converting enzyme inhibitors after acute myocardial infarction?
    Tu K; Gunraj N; Mamdani M
    Am J Cardiol; 2006 Jul; 98(1):6-9. PubMed ID: 16784910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
    Ueshima K; Fukami K; Hiramori K; Hosoda S; Kishida H; Kato K; Fujita T; Tsutani K; Sakuma A;
    Am Heart J; 2004 Aug; 148(2):e8. PubMed ID: 15309011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.
    Leor J; Reicher-Reiss H; Goldbourt U; Boyko V; Gottlieb S; Battler A; Behar S
    J Am Coll Cardiol; 1999 Jun; 33(7):1920-5. PubMed ID: 10362194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.